VITEK 2 BCL Test Kit recalled for storage condition violations
A batch of VITEK 2 Reagent BCL Test Kit from Biomerieux Inc is being recalled because storage conditions were exceeded, and product performance cannot be guaranteed.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall based on storage condition violation that cannot guarantee product performance. No illnesses, injuries, or actual harm reported. This meets the criteria for Moderate severity as a precautionary quality-control-based recall without documented harm.
Plain-English summary
The VITEK 2 Reagent BCL Test Kit (Catalog 21345) manufactured by Biomerieux Inc is being recalled due to storage condition violations affecting batch 2392195203.
The product was stored outside of the acceptable temperature and time ranges. As a result, the product's performance cannot be guaranteed.
The affected batch was distributed nationwide in the United States.
The recalled product
- Product
- VITEK 2 REAGENT BCL TEST KIT VTK2 20 CARDS, CATALOG 21345
- Manufacturer
- Biomerieux Inc
- Hazard
- storage-condition-violation
- performance-degradation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- UDI/DI 353026131951
- Batch Numbers: 2392195203
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereMedline Spinal Block Kits Recalled for Data Integrity and Efficacy Issues
FDA (Devices) · 2026-06-03
- SevereAbiomed Automated Impella Controller recalled for motor control and pump failure risks
FDA (Devices) · 2026-06-03
- HighGE APEXPRO and CARESCAPE Telemetry Systems Risk Loss of Patient Monitoring
FDA (Devices) · 2026-06-03
- CriticalMedline spinal anesthetic kits recalled for quality and efficacy concerns
FDA (Devices) · 2026-06-03
- SevereMedline spinal anesthesia kits recalled for bupivacaine quality issues
FDA (Devices) · 2026-06-03